Particulate Technology for Delivery of Therapeutics (PDF)

development synthetic methodologies. He is also studied the recognition process in solution phase as well as in solid state. Overall he extensively studied on supramolecular behaviour of the host-guest interaction. Besides, he has worked on the development of synthetic methodologies for substituted heterocyclics like pyrimidines, naphthyridines, quinoline and diazepines etc. by exploiting microwave protocol for green chemical synthesis.  After that he moved to University of Victoria, Canada, to work with Dr Fraser Hof on supramolecular and medicinal chemistry as a post-doctoral fellow, where he worked on the synthesis of different receptors targeting N-methylated protein residue along with anions. He then worked further with Dr Kenneth J Woycechowsky at University of Utah, USA, on protein engineering and enzyme catalysis as post-doctoral research associate. He studied of enzyme activity when it is encapsulated inside the capsid which is a nano carrier and an excellent delivery vehicle for important biological substrate including drug molecules. Presently, he is working as Associate Professor at Department of Chemistry, Indira Gandhi National Tribal University, Amarkantak, Madhya Pradesh, India and his current research focuses on design and synthesis of artificial receptors for the recognition of anions, cations and N-methylated protein residue. He is also working on biodegradable polymeric based carrier systems for the delivery of drug molecules by collaboration with pharmaceutical scientist. So far he has published ~40 research paper in peer reviewed international journals and contributed more than 10 book chapters in different edited books published by internationally renowned publishers. He also serve as editorial board member for the Journal of PharmaSciTech (ISSN: 2231 3788) and International Journal of Scientific and Engineering Research (ISSN: 2229-5518) as well as reviewer for International Journal of Biological Macromolecule (Elsevier), Journal of PharmaSciTech and Current Pharmaceutical Design (Bentham).